Unless stated all financials at 30 Spetember 2025
£1.02bn
Net assets
167.9p
NAV per share
(1.7)%
NAV per share return in the year
£750m
Value of life science portfolio
(1.7)%
Return from life science portfolio in the year
£271m
Capital pool